most common side effects of glp 1 GI Adverse Glucagon-Like Peptide-1 Receptor Agonists risks of glp 1 drugs

Clinical trial data have generated significant interest in retatrutide because of its substantial weight-loss results, including Phase 3 findings showing average body weight reductions of more than 30% at the highest studied dose over 80 weeks

Become a valued research partner with us, please feel free to contact us at [email protected]

Diabetes Metab Res Rev 2016;33

In 2026, results from a larger and longer phase 3 trial supported these findings

Gradual reintroduction of soluble fiber (such as oats or psyllium) after initial symptom control supports long-term digestive health and may help prevent constipation, which can contribute to bloating

You can connect with a licensed doctor to discuss your eligibility for medications like Wegovy and Zepbound, all from the privacy and convenience of your home